CIK 0001728117 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Revenue (USD) | 48.5 M | 0 | ||
| Net income (USD) | -229.4 M | -234.0 M | -243.4 M | |
| Diluted EPS (USD/shares) | -0.75 | -2.71 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-08 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-09-28 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-09-28 | 8-K | 8-K items 8.01 | 2026-09-25 |
| 2026-09-25 | 4 | FORM 4 | 2026-09-23 |
| 2026-09-25 | 4 | FORM 4 | 2026-09-23 |
| 2026-09-25 | 4 | FORM 4 | 2026-09-23 |
| 2026-09-25 | 4 | FORM 4 | 2026-09-23 |
| 2026-09-25 | 4 | FORM 4 | 2026-09-23 |
| 2026-09-25 | 4 | FORM 4 | 2026-09-23 |
| 2026-09-25 | 4 | FORM 4 | 2026-09-23 |
| 2026-09-23 | 8-K | 8-K items 8.01 | 2026-09-23 |
| 2026-09-22 | 3 | FORM 3 | 2026-09-16 |
| 2026-09-16 | DEF 14A | DEF 14A | 2026-10-27 |
| 2026-09-16 | 8-K | 8-K items 5.02,9.01 | 2026-09-16 |
| 2026-09-11 | 8-K | 8-K items 3.03,5.03,8.01,9.01 | 2026-09-10 |
| 2026-09-09 | 8-K | 8-K items 8.01,9.01 | 2026-09-09 |
| 2026-09-04 | D | D items 06b | |
| 2026-09-03 | PRE 14A | PRE 14A | 2026-09-03 |
| 2026-09-03 | 8-K | 8-K items 5.03,9.01 | 2026-09-03 |
| 2026-08-26 | 4 | FORM 4 | 2026-08-24 |
| 2026-08-26 | 4 | FORM 4 | 2026-08-24 |
| 2026-08-26 | 4 | FORM 4 | 2026-08-24 |
| 2026-08-26 | 4 | FORM 4 | 2026-08-24 |
| 2026-08-26 | 4 | FORM 4 | 2026-08-24 |
| 2026-08-26 | 8-K | 8-K items 5.03,9.01 | 2026-08-24 |
Forms on file (last 1,000): 4 205, 8-K 87, 10-Q 23, 3 22, SC 13G/A 18, SC 13G 15, DEF 14A 10, DEFA14A 10. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=GOSS (0.002 USD), /gw/filings/filings?ticker=GOSS&form=8-K, /gw/filings/facts?ticker=GOSS&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange